We showed earlier that cellular retinol-binding protein (CRBP) expression is downregulated in a subset of human breast cancers. We have now investigated the outcome of ectopic CRBP expression in MTSV1-7 cells, a SV40 T antigen-transformed human breast epithelial cell line devoid of endogenous CRBP expression. We found that: (i) CRBP did not inhibit adherent cell growth but suppressed foci formation in post-con¯uent cultures and colony formation in soft agar; (ii) this eect was due to CRBP inhibition of cell survival, as demonstrated by viability and TUNEL assays of cells in soft-agar or plated on polyHEMA-coated dishes; (iii) CRBP inhibited protein kinase B/Akt activation in cells in suspension but not in adherent cells and the CRBP suppression of anchorage-independent growth was mimicked by cell treatment with the phosphatidylinositol-3 kinase (PI3K) inhibitor LY294002; (iv) CRBP enhanced retinyl ester formation and storage but did not regulate retinoic acid synthesis or retinoic acid receptor activity. Ectopic CRBP-mediated inhibition of anchorage-independent cell survival and colony formation in the absence of signi®cantly altered responses to either retinol or retinoic acid was also documented in T47D human breast cancer cells. In conclusion, the data suggest two novel and linked CRBP functions in mammary epithelial cells: inhibition of the PI3K/Akt survival pathway and suppression of anchorage-independent growth. Oncogene (2001) 20, 7413 ± 7419.
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Keywords: FABP; soft agar; anoikis; retinol; retinoic acid CRBP is a 15 kDa cytosolic protein that binds retinol with high anity and is postulated to regulate the intracellular fate of retinol. For instance, CRBP is known to regulate liver retinol esteri®cation and storage (Ghyselinck et al., 1999) and may also regulate retinol oxidation to retinoic acid in target tissues (Napoli, 1999; Yamamoto et al., 1998) . CRBP is widely expressed in epithelial tissues, whereas its homologs, CRBPII and two novel CRBPs have more restricted tissue distributions (Vogel et al., 2000; Folli et al., 2001) . CRBPs are the only retinol-binding members of the large family of fatty-acid binding proteins (FABPs; reviewed in Glatz and van der Vusse (1996) .
We recently reported that human breast carcinogenesis is associated with the loss of CRBP expression in roughly one fourth of breast cancer cases . To begin to investigate the possible signi®cance of this ®nding, we reconstituted CRBP expression in CRBP-negative MTSV1-7 cells and assayed the eect of this intervention on cell growth. MTSV1-7 (abbreviated MTS) is a human breast ductal epithelial cell line that was immortalized by introduction of the SV40 T antigen (Bartek et al., 1991) and that upon continued culture in our laboratory acquired the ability to form foci and colonies in soft agar (YS Kuppumbatti et al., in preparation) . Stable re-expression of CRBP in MTS cells ( Figure 1a ) had no eect on exponential monolayer growth (Figure 1b ) but blocked the formation of foci in post-con¯uent cultures ( Figure 1c) . Moreover, CRBP re-expression strongly inhibited colony formation in soft agar (Figure 1d,e) . These results, obtained with pools of transfected cells, were con®rmed by stably transfecting CRBP into the vector-transfected pool (Figure 1d ,e). Ectopic CRBP expression in T47D breast cancer cells, a low CRBP expressor also induced marked inhibition of anchorageindependent growth (Figure 1e, inset) . Western blot analysis revealed that reconstituted CRBP protein expression levels (MTS-C) were lower than endogenous CRBP protein levels in primary cultures of mouse mammary epithelial cells (data not shown). Taken together, these results suggest that CRBP is a suppressor of anchorage-independent growth in at least two cellular contexts relevant to breast cancer when expressed at levels that may approximate those in normal human breast epithelial cells.
How does CRBP suppress anchorage-independent growth? Because CRBP did not regulate adherent cell Figure 1 CRBP inhibition of foci formation and anchorage-independent growth. (a) CRBP immunoblot analysis. MTS-V and MTS-C are pools of vector-transfected and CRBP-transfected cells generated by cotransfection of pSG5 or pSG5.mCRBP and pSV2neo, respectively, followed by G418 selection. MTS-VV and MTS-VC are clones derived from MTS-V after a second round of stable transfection with pcDNA3.1/Hygro+ without or with mCRBP cDNA insert, respectively. Cytosols were prepared as described and 50 mg protein loaded per lane. Anti-CRBP antibody was raised in rabbits against a keyhole limpet hemocyanin-conjugated CRBP-speci®c peptide (Busch et al., 1990 ) using standard techniques. The antiserum was puri®ed by peptide anity chromatography and shown to detect a single 15 kDa band in liver cytosol at 1 : 200 dilution by enhanced chemiluminescence. (b) Growth curves. Cells were plated at 10 4 cells/60 mm dish in growth medium (Bartek et al., 1991) and cell number evaluated at the time points indicated using the crystal violet assay (Gillies et al., 1986) . Ordinate shows the total growth and therefore did not appear to alter the cell cycle (Figure 1b) , we hypothesized that it altered cell survival. In support of this hypothesis, we found that the viability of CRBP-expressing MTS and T47D cells in soft agar was consistently lower than that of control cells (Figure 2a ). In further experiments with the MTS cell model, we found that CRBP-expressing cells plated on poly-HEMA-coated dishes to prevent cell attachment also survived poorly as assessed by Trypan blue exclusion. In both experimental settings the survival advantage of vector-transfected cells increased over time (data not shown). Moreover, TUNEL staining revealed that suspended CRBPexpressing cells were undergoing apoptosis at a greater rate than control cells (Figure 2b ). These results suggest that CRBP inhibited colony formation in soft agar by enforcing anoikis, the apoptotic program that normally ensures the death of cells that are not anchored to the extracellular matrix (Frisch and Francis, 1994) .
We next asked whether CRBP targeted the PI3K/ Akt survival pathway, which has been implicated in anoikis (Lu et al., 1999; Rytomaa et al., 1999) . MTS cells were plated on poly-HEMA-coated dishes and the state of Akt activation (p-Akt/Akt ratio) monitored over 48 h. As shown in Figure 2c , this ratio decreased progressively with time in suspension in CRBPexpressing cells but not in control cells. The speci®city of this eect is suggested by the ®nding that CRBP had no eect on Akt activity in adherent cells or on Erk1,2 MAPK activity in suspended cells (Figure 2c) . Interestingly, treatment with the PI3K inhibitor LY294002 mimicked the suppressive eect of CRBP on anchorage-independent growth (Figure 2d ). These results suggest that the CRBP inhibition of PI3K/Akt explains, at least in part, the CRBP inhibition of anchorage-independent growth.
What is the link between CRBP and PI3K/Akt activity, cell survival and anchorage-independent growth? Because all-trans retinoic acid (RA) has been shown to promote apoptosis and to inhibit anchorage-independent growth in breast cancer cells (Dawson et al., 1995; Liu et al., 1996; Sapi et al., 1999; Seewaldt et al., 1995) and because CRBP has been postulated to regulate retinol conversion to RA (Napoli, 1999; Yamamoto et al., 1998) , we hypothesized that the eects of CRBP were secondary to increased RA synthesis and RA receptor (RAR) activation. Figure 3 demonstrates that CRBP-expressing cells exhibited two known properties of CRBP, increased retinol-binding and increased retinyl ester formation and storage. However, all attempts to demonstrate an eect of CRBP on RA synthesis or ligand availability failed. Thus, the levels of RA generated from 0.5 ± 2 mM retinol were not signi®-cantly altered by CRBP expression in MTS cells, which have an active RA synthesizing machinery, or in T47D cells, which synthesized only trace amounts of RA regardless of CRBP expression (Figure 4a ). Semi-quantitative and real-time RT ± PCR analyses showed that expression of RARb2, a classical RA target gene, was comparable in MTS-V and MTS-C cells, implying similar ligand availability (Figure 4b) . Because T47D cells are ER positive and highly responsive to exogenous RA-induced growth arrest, we tested whether CRBP expression altered the abundance of either ER or RARa, an ER target gene (Sun et al., 1998) . No signi®cant dierences were observed (Figure 4c) . Further, the response of T47D cells to either exogenous retinol or RA was not much altered by CRBP expression, with the exception of an apparent enhancement of response to pharmacological retinol doses (Figure 4d ). Unlike T47D cells, MTS cells are ER negative and poorly responsive to exogenous RA (Jing et al., 1997; Miray-Lopez et al., 2000) and neither retinol (2 mM) nor RA (1 mM) treatment was eective in suppressing MTS tumor cell survival (48 h, serum omitted) or anchorage-independent growth (3 weeks, serum present; data not shown). These ®ndings suggest that the eects of CRBP we have reported were not due to CRBP regulation of RAR activity. Further experiments are needed to address the issue of whether retinol-binding by CRBP is or is not required for growth suppression.
Interestingly, two fatty acid-binding members of the FABP family have been shown to inhibit anchorageindependent growth or tumorigenicity in human breast cancer cells (Huynh et al., 1995; Shi et al., 1997) . While it remains conceivable that CRBP and certain FABPs suppress colony formation in soft agar by regulating the availability of ligands (RA or fatty acids) to nuclear receptors (RARa,b or PPARg, respectively) that then inhibit anchorage-independent growth (Brockman et al., 1998; Chang and Szabo, 2000; Dawson et al., 1995; Sapi et al., 1999) , our data suggest that alternative mechanisms should be contemplated. Recent evidence suggests that heart-FABP (also known as mammary-derived growth inhibitor) inhibits the anchorage-independent growth of human (4000) were seeded in 2 ml of 0.4% agar in growth medium over a 3 ml base layer of 1% agar also in growth medium. Each culture was topped with 1 ± 2 ml of medium every 3 ± 5 days. After 3 weeks, colonies were stained with methylene blue. Similar results were obtained in a minimum of two repeat experiments. (e) Number of colonies obtained in one experimental series with all MTS cell preparations. Colonies estimated to contain 440 cells were counted with the aid of a scanner and the NIH imaging program. Insert: Colony number in soft agar for T47D clones generated by cotransfection of pSG5 (V) or pSG5.mCRBP (C) and pSV2neo, respectively, followed by G418 selection (CRBP expression levels were similar to those shown in a)
Figure 2 CRBP inhibits cell survival. (a) Cell viability in soft agar. Two days after seeding 20 000 cells in soft agar, the cultures were overlayed with medium containing 2 mg/ml MTT tetrazolium dye and incubated for 3 h. Viable (MTT positive) and nonviable (MTT negative) cell numbers were then estimated by counting at least 10 ®elds at 1006 magni®cation, totaling 300 ± 500 cells. Because colony-forming eciency is 5 ± 20% (Figure 1 ), cell death is also seen in the control cells. (b) Apoptosis of cells in suspension culture. MTS-V and MTS-C cells (1.5610 6 ) were seeded in serum-free medium in 100 mm dishes coated with polyHEMA as described (Li et al., 1999) . Twenty-four hours later, cytospins were processed for TUNEL staining according to manufacturer's instructions (Roche Biochemicals). Representative ®eld is shown. The percentage of TUNEL positive cells was estimated from 3 ± 4 independent ®elds of *200 cells as 8+2% (MTS-V) and 88+4% (MTS-C). (c) Akt phosphorylation of cells in suspension. MTS-V and MTS-C cells were seeded as above and, at the times indicated, total cell lysates (50 mg/lane), were probed with anti-Akt or anti-phospho Akt (P-Ser472/473/474) antibodies according to the manufacturer's instructions (Pharmingen). Also shown is the lack of a CRBP eect on Erk1,2 MAPK activation under the same conditions and Akt activation in adherent cells (anti-phospho-Erk, P-Tyr 204, from Santa Cruz and anti-Erk from Transduction Laboratories). (d) Eect of LY294002. MTS-V cells were suspended for 6 h in serum-free medium without or with 10 mM LY294002 and Akt phosphorylation monitored as above. To test the eect of 10 mM LY294002 on MTS-V anchorage-independent growth, the inhibitor was included in the top agar layer and in the 1 ± 2 ml of overlaying medium, which was replenished every 3 ± 5 days breast cancer cells through a mechanism that is independent of fatty acid-binding (Wang and Kurtz, 2000) . The observation that PI3K is associated with lipid bodies in leukocytes (Yu et al., 1998 (Yu et al., , 2000 is also of potential interest in view of the eect of CRBP on lipid droplet formation (Figure 3c ). These ®ndings, along with the recent observation that CRBP can localize to the cell nucleus (Ru and Ong, 2000) , highlight the potential for hitherto unsuspected mechanisms of CRBP action.
In sum, we have demonstrated that CRBP reexpression in two human breast cancer models results in suppression of anchorage-independent growth through the inhibition of cell survival. Our data suggest that CRBP targeting of the PI3K/Akt pathway accounts at least in part for the inhibition of cell survival. The underlying mechanism remains to be identi®ed but appears to be independent of CRBP regulation of RAR activity. Retinyl ester formation. Post-con¯uent MTS cultures were extracted and retinyl ester content evaluated by HPLC as described (Pappas et al., 1993) . Bars show mean total content of retinyl esters normalized to total cell protein (bullets show individual data points). (c) Electron micrographs of the cells analysed in (b) depicting the larger lipid (retinyl ester-containing) droplet size in post-con¯uent CRBP-expressing MTS-C cells (bottom) as compared to vector-transfected MTS-V cells (top). L, lipid droplets (both electron-dense and translucent lipid droplets can be seen); N, nucleus. Scale bar=4 mM Figure 4 CRBP does not enhance RAR activity. (a) RA synthesis from retinol. Semi-con¯uent cultures were treated with 0.5 mM (MTS cells) or 2 mM retinol (T47D cells) and 8 mM BSA for 4 h and the amount of RA synthesized determined by cell extraction and HPLC analysis as described . Bars depict the mean of duplicate determinations (bullets show individual values). In T47D cells, the trace levels of RA detected amounted to 1.3 ± 1.5 fmols RA/mg in vector-transfected clones and 0.9 ± 2.9 fmols RA/mg protein in CRBP-expressing clones. (b) Real-time RT ± PCR. Primers were as follows: RARb2 sense 5'-cca cac cta gag gat aag cac-3' (exon 3), antisense 5'-gtg gta ccc tga tga ttt gtc c-3' (exon 4); b-actin sense 5'-gcc cag agc aag aga ggt at-3', antisense 5'-ccg gta gag gac gag ctt ca-3'. Preliminary runs (annealing at 628C) indicated single band products of the expected size. The dierence (RARb2-actin) in lower threshold cycles (Ct) is shown (the greater the dierence, the lower the RAR2b expression level). Because under regular growth conditions serum retinol is converted to RA, treatment with the RAR antagonist Ro 41-5253 was used to de®ne a true baseline of RARb2 expression. Semi-quantitative RT ± PCR performed as described (Arapshian et al., 2000) 
